These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
275 related items for PubMed ID: 25166221
1. A Comparison of Short-Term Growth During Treatment with Two Dry Powder Combinations of Inhaled Corticosteroids and Long-Acting β₂-Agonists. Wolthers OD, Shah T. J Aerosol Med Pulm Drug Deliv; 2015 Jun; 28(3):182-8. PubMed ID: 25166221 [Abstract] [Full Text] [Related]
3. Evaluation of inhaler technique and achievement and maintenance of mastery of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in adult patients with asthma: the Easy Low Instruction Over Time (ELIOT) study. Price DB, Thomas V, Richard Dekhuijzen PN, Bosnic-Anticevich S, Roche N, Lavorini F, Raju P, Freeman D, Nicholls C, Small IR, Sims E, Safioti G, Canvin J, Chrystyn H. BMC Pulm Med; 2018 Jun 28; 18(1):107. PubMed ID: 29954359 [Abstract] [Full Text] [Related]
6. Real-world effectiveness evaluation of budesonide/formoterol Spiromax for the management of asthma and chronic obstructive pulmonary disease in the UK. Voorham J, Roche N, Benhaddi H, van der Tol M, Carter V, van Boven JFM, Bjermer L, Miravitlles M, Price DB. BMJ Open; 2018 Oct 27; 8(10):e022051. PubMed ID: 30368448 [Abstract] [Full Text] [Related]
8. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler. Berger WE, Noonan MJ. J Asthma; 2010 May 27; 47(4):447-59. PubMed ID: 20528601 [Abstract] [Full Text] [Related]
9. Efficacy, safety, and pharmacokinetics of budesonide/formoterol fumarate delivered via metered dose inhaler using innovative co-suspension delivery technology in patients with moderate-to-severe COPD. Kerwin EM, Siler TM, Arora S, Darken P, Rose E, Reisner C. Int J Chron Obstruct Pulmon Dis; 2018 May 27; 13():1483-1494. PubMed ID: 29773947 [Abstract] [Full Text] [Related]
10. Onset of action of budesonide/formoterol Spiromax(®) compared with budesonide/formoterol Turbuhaler(®) in patients with COPD. Cazzola M, Ora J, Di Paolo A, Puxeddu E, Calzetta L, Rogliani P. Pulm Pharmacol Ther; 2016 Aug 27; 39():48-53. PubMed ID: 27344046 [Abstract] [Full Text] [Related]
11. Knemometry Assessment of Short-term Growth in Children With Asthma Receiving Fluticasone Furoate for 2 Weeks: A Randomized, Placebo-controlled, Crossover Trial. Wolthers OD, Stone S, Bareille P, Tomkins S, Khindri S. Clin Ther; 2017 Jun 27; 39(6):1191-1199. PubMed ID: 28545804 [Abstract] [Full Text] [Related]
12. Inhalation characteristics of asthma patients, COPD patients and healthy volunteers with the Spiromax® and Turbuhaler® devices: a randomised, cross-over study. Azouz W, Chetcuti P, Hosker H, Saralaya D, Chrystyn H. BMC Pulm Med; 2015 May 01; 15():47. PubMed ID: 25927483 [Abstract] [Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients. Daley-Yates PT, Mehta R, Chan RH, Despa SX, Louey MD. J Aerosol Med Pulm Drug Deliv; 2014 Aug 01; 27(4):279-89. PubMed ID: 24074143 [Abstract] [Full Text] [Related]
18. Effects of beclomethason/formoterol and budesonide/formoterol fixed combinations on lung function and airway inflammation in patients with mild to moderate asthma--an exploratory study. Kirsten AM, Watz H, Brindicci C, Piccinno A, Magnussen H. Pulm Pharmacol Ther; 2015 Apr 01; 31():79-84. PubMed ID: 25194884 [Abstract] [Full Text] [Related]